Related Experiment Videos
Estrogen replacement therapy and retinal vascular caliber.
Tien Yin Wong1, Michael D Knudtson, Barbara E K Klein
1Centre for Eye Research Australia, University of Melbourne, Melbourne, Australia. ophwty@nus.edu.sg
Ophthalmology
|April 6, 2005
Summary
Estrogen replacement therapy (ERT) is linked to narrower retinal blood vessels in women. This finding suggests a potential impact of ERT on ocular circulation, independent of blood pressure.
Area of Science:
- Ophthalmology
- Endocrinology
- Vascular Biology
Background:
- The effect of estrogen replacement therapy (ERT) on retinal circulation remains unclear.
- Understanding ERT's impact on retinal vascular caliber is crucial for women's health.
Purpose of the Study:
- To investigate the association between ERT, female reproductive factors, and retinal vascular caliber.
- To determine if ERT influences retinal arteriolar and venular diameters.
Main Methods:
- Population-based cross-sectional study involving 2469 women aged 43-84 in Beaver Dam, Wisconsin.
- Retinal photographs were analyzed to measure arteriolar and venular diameters.
- Estrogen replacement therapy and reproductive factors were assessed via interview.
Main Results:
- Current ERT users exhibited significantly narrower retinal arteriolar (167.6 µm) and venular (239.9 µm) diameters compared to past or never users.
- A significant trend of increasing vascular narrowing was observed with longer ERT duration.
- Associations were more pronounced in younger women and those without hypertension or smoking history.
Conclusions:
- Estrogen replacement therapy is independently associated with narrower retinal vessel diameters.
- These findings suggest ERT influences retinal vascular caliber, irrespective of blood pressure and other vascular risk factors.